Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Weight loss injections are administered with a needle under the skin. Some injectable prescription medications, like liraglutide (Saxenda®) and tirzepatide (Zepbound® and Mounjaro®), support ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are ...

F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...

New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

accusing them of marketing knockoff versions of its diabetes and weight-loss drugs. Dr. Brett Osborn, a West Palm Beach neurosurgeon and longevity doctor who has prescribed pharmaceutical-grade ...